Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Clinical trial to evaluate a progressive,enhanced depth-of-focus intraocular lens with multiple focal points

Search Title by author or title

Session Details

Session Title: Pseudophakic IOLs: Enlarged-Depth-of-Focus II

Session Date/Time: Monday 12/09/2016 | 16:00-18:00

Paper Time: 16:36

Venue: Hall C3

First Author: : R.Gerl GERMANY

Co Author(s): :    M. Mueller   D. Breyer   H. Kaymak   G. Auffarth   M. Gerl   F. Kretz     

Abstract Details

Purpose:

Clinical evaluation of a wavefront designed progressive intraocular lens (prIOL) with multiple focal points.

Setting:

Multi-center study of the International Vision Correction Research Centre Network (IVCRC.net), Univ. of Heidelberg, Germany

Methods:

In a prospective, multicenter study, patients that underwent cataract surgery or refractive lens exchange with a calculated postoperative astigmatism ≤ 1.5 D were evaluated. All patients recieved monocular or binocular implantation of the prIOL (Miniwell, Sifi, Italy). The preoperative biometry was performed with the IOL-Master (700, Carl Zeiss Meditech). All IOL powers were calculated with the Holladay formula closed to emmetropia from the myopic side. Subjective refraction, CDVA, UDVA, UIVA, DCIVA, UNVA and DCNVA, monocular and binocular [logMar] were evaluated. Additionally contrast sensitivity and defocus curve analysis were performed.

Results:

3 month postoperative the mean monocular UDVA, UIVA and UNVA were 0.1, respectively. In cases of binocularity there was a significant improvement in visual acuity in all distances. The defocus curve shows a plateau in the from distance to intermediate comparable to trifocal IOLs. The patient satisfaction was very high.

Conclusions:

The prIOL shows gut results for all distances evaluated resulting in a high rate of spectacle independence.

Financial Disclosure:

... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, ... travel has been funded, fully or partially, by a competing company, ... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... research is funded, fully or partially, by a competing company, ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... receives consulting fees, retainer, or contract payments from a competing company

Back to previous